Pavia, Italy

Gianenrico Rovati

This inventor holds 1 USPTO granted patent. Top assignees: Consiglio Nazionale Delle Ricerche, Universita' Degli Studi Di Pisa, Universita′ Degli Studi Di Milano. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gianenrico Rovati. Retrieved from https://idiyas.com/inventor/gianenrico-rovati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gianenrico Rovati: Innovator in GPR17 Modulation

Introduction

Gianenrico Rovati is a notable inventor based in Pavia, Italy. He has made significant contributions to the field of medical research, particularly in the area of GPR17 modulation. His work focuses on developing methods for diagnosing and treating diseases related to GPR17 activation.

Latest Patents

Rovati holds a patent for "GPR17 modulators, method of screening and uses thereof." This invention provides GPR17 modulators and outlines methods for screening and utilizing these modulators for the diagnosis and therapy of diseases or dysfunctions involving GPR17 activation, especially in cases of ischemic brain damage. He has 1 patent to his name.

Career Highlights

Throughout his career, Gianenrico Rovati has worked with prestigious institutions such as Università Degli Studi di Milano and Università Degli Studi di Pisa. His research has contributed to advancements in understanding the role of GPR17 in various medical conditions.

Collaborations

Rovati has collaborated with esteemed colleagues, including Maria Pia Abbracchio and Paolo Ciana. Their joint efforts have furthered research in the field of GPR17 and its implications in medical science.

Conclusion

Gianenrico Rovati's innovative work in GPR17 modulation highlights his commitment to advancing medical research. His contributions are paving the way for new diagnostic and therapeutic approaches to treat ischemic brain damage and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…